SCHEDULE 13G/A: Vanguard Group Discloses 11.49% Stake in GE HealthCare Technologies Inc.
Beneficial Ownership Report
The Vanguard Group has filed an amended Schedule 13G, revealing its beneficial ownership of 11.49% of GE HealthCare Technologies Inc.'s common stock as of December 31, 2024.
Summary
- The Vanguard Group, a major investment adviser, reported beneficial ownership of 52,535,829 shares of GE HealthCare Technologies Inc. common stock.
- This ownership represents 11.49% of the total class of securities.
- Vanguard holds sole dispositive power over 50,488,390 shares and shared dispositive power over 2,047,439 shares.
- The firm has shared voting power over 545,310 shares and no sole voting power.
- The filing certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the disclosure of a significant stake by a major institutional investor like Vanguard can be interpreted as a vote of confidence in the company. However, it's a routine disclosure without new financial performance data.
Positives
- The disclosure of a significant stake by a large, reputable institutional investor like The Vanguard Group can signal confidence in GE HealthCare Technologies Inc.'s long-term prospects.
- Vanguard's holding of 11.49% indicates a substantial commitment to the company's stock.
Future Outlook
This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance.
Industry Context
The filing reflects a routine disclosure by a major asset manager regarding its passive investment in a prominent healthcare technology company. Such disclosures are common for large institutional investors holding significant stakes across various industries.
Stakeholder Impact
- Shareholders: The presence of a large, passive institutional investor like Vanguard can provide stability and liquidity to the stock, potentially reassuring other investors.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires the filing of this statement (reporting period end date). |
| 01/30/2025 | Date the Schedule 13G Amendment No. 2 was signed by The Vanguard Group. |
Keywords
GE HealthCare Technologies Inc., Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Healthcare Technology, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.